| Date |
Title |
Rating |
| 2011-08-31 |
Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection |
None |
| 2011-08-31 |
Eisai announces results of perampanel Phase III study on epilepsy |
None |
| 2011-08-31 |
Positive results from Bionovo's Menerba tolerability trial on menopausal hot flashes |
None |
| 2011-08-31 |
Enrollment commences in Adamis' APC-100 Phase 1/2a clinical prostate study |
None |
| 2011-08-31 |
Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD |
None |
| 2011-08-31 |
Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD |
None |
| 2011-08-30 |
Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting |
None |
| 2011-08-30 |
Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development |
None |
| 2011-08-30 |
ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma |
None |
| 2011-08-30 |
Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress |
None |
| 2011-08-30 |
Bristol Meyer Squibb’s new blood thinner drug for stroke prevention |
None |
| 2011-08-29 |
Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer |
None |
| 2011-08-29 |
Dabigatran etexilate superior to warfarin for stroke prevention in AF patients |
2 |
| 2011-08-29 |
Everolimus-eluting stent and SES are equally effective for PCI patients |
None |
| 2011-08-29 |
Statins protect people against death from respiratory illness, infections |
None |
| 2011-08-29 |
ELIQUIS better than warfarin in reduction of stroke, major bleeding, and mortality |
None |
| 2011-08-29 |
Colchicine more effective than placebo for recurrent pericarditis |
None |
| 2011-08-29 |
Apixaban superior to warfarin in preventing stroke and systemic embolism |
None |
| 2011-08-29 |
Azithromycin can help reduce wheezing, other acute symptoms of COPD |
None |
| 2011-08-26 |
BIPI to launch dabigatran etexilate Phase II trial in patients with mechanical heart valves |
None |
| 2011-08-26 |
Fludrocortisone may help reduce unexplained chronic nausea in children |
5 |
| 2011-08-26 |
Nasal spray with hot chili pepper ingredient may help people clear up sinus inflammation |
None |
| 2011-08-26 |
Emergent announces results of adjuvanted BioThrax anthrax vaccine Phase 1a trial |
None |
| 2011-08-25 |
Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder |
5 |
| 2011-08-25 |
PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine |
None |
| 2011-08-25 |
Azithromycin can effectively reduce acute COPD exacerbations |
None |
| 2011-08-24 |
Psoriasis drug and heart attack risk association unclear: Study |
None |
| 2011-08-24 |
KFDA approves IND for DP-b99 Phase III MACSI stroke study in Korea |
None |
| 2011-08-24 |
Kibow renews exclusive worldwide veterinary licensing and marketing agreement |
None |
| 2011-08-24 |
United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH |
None |
| 2011-08-24 |
Avastin increases tumor response rates in breast cancer patients before surgery |
None |
| 2011-08-24 |
Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease |
None |
| 2011-08-24 |
Seattle Genetics initiates ADCETRIS phase II trial in CD30-positive non-Hodgkin lymphoma |
4 |
| 2011-08-23 |
Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia |
None |
| 2011-08-23 |
Pearl selects TransPerfect's Trial Interactive eTMF solution for clinical development programs |
3 |
| 2011-08-23 |
Spinifex secures AU$6.25 million in expanded Series B funding |
None |
| 2011-08-23 |
Symphogen initiates Sym004 Phase 2 trial in squamous cell carcinoma of head and neck cancer |
1 |
| 2011-08-22 |
Living Cell Technologies xenoimplants first patients in Argentina trial |
None |
| 2011-08-20 |
Researchers turn their attention to Chagas disease as developed countries see rise in infection rates |
None |
| 2011-08-19 |
VOA News examines ethics of clinical drug testing in African nations |
None |
| 2011-08-19 |
Time-release corticosteroid implant effective in treating uveitis |
None |
| 2011-08-19 |
Amgen to present data from several Prolia studies at ASBMR 2011 meeting |
None |
| 2011-08-19 |
NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy |
None |
| 2011-08-19 |
Minocycline, EDTA may combat catheter-related bacterial infections in dialysis patients |
3 |
| 2011-08-19 |
FDA grants Fast Track designation for DARA's KRN5500 neuropathic pain relief drug |
None |
| 2011-08-19 |
Antigen Express provides update on ongoing AE37 Phase 2 trial in breast cancer |
None |
| 2011-08-18 |
BTI completes SUGARDOWN human clinical study on blood sugar management |
None |
| 2011-08-18 |
New leukemia drug in early clinical testing offers some clues for better treatment |
None |
| 2011-08-18 |
FDA approves Mayo Clinic's ovarian and breast cancer vaccines |
None |
| 2011-08-18 |
NCRM at Case Western Reserve to host stem cell conference in Cleveland |
None |
| 2011-08-18 |
Clinical trials to evaluate and validate infrastructure of P-medicine consortium |
None |
| 2011-08-18 |
Endo terminates collaboration and axomadol development program with Grunenthal |
None |
| 2011-08-18 |
CEL-SCI receives Chinese patent for Multikine cancer drug |
None |
| 2011-08-18 |
Enrollment commences in Allos' FOLOTYN Phase 3 trial for peripheral T-cell lymphoma |
None |
| 2011-08-17 |
Emergent commences TRU-016 Phase 1b/2 combination trial in relapsed indolent NHL |
4 |
| 2011-08-17 |
Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer |
None |
| 2011-08-17 |
GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program |
None |
| 2011-08-17 |
Clinical Trials Partnership Middle East Summit to take place in Dubai |
None |
| 2011-08-17 |
Pegloticase can improve clinical outcomes of patients with chronic gout |
None |
| 2011-08-17 |
Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial |
None |
| 2011-08-17 |
FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients |
None |
| 2011-08-17 |
Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer |
None |
| 2011-08-16 |
Patrys product shows activity in multiple myeloma cancer cells |
None |
| 2011-08-16 |
LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease |
5 |
| 2011-08-16 |
Zinc lozenges might reduce duration of common cold episodes by 40% |
None |
| 2011-08-16 |
Pfizer, QIAGEN partner to develop diagnostic-therapeutic combination for NSCLC |
None |
| 2011-08-16 |
AVI BioPharma, MDA to initiate exon-51 Phase 2 trial in Duchenne muscular dystrophy |
None |
| 2011-08-16 |
Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia |
None |
| 2011-08-16 |
Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome |
None |
| 2011-08-16 |
Toclizumab for juvenile rheumatoid arthritis |
None |
| 2011-08-15 |
Starpharma starts bacterial vaginosis prevention study of VivaGel |
None |
| 2011-08-15 |
Arrythmia drug may work in stroke prevention: Study |
1 |
| 2011-08-11 |
Pacira second quarter total revenues increase to $3.6 million |
None |
| 2011-08-11 |
Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV |
None |
| 2011-08-11 |
Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS |
None |
| 2011-08-11 |
Positive results from two ADL5945 Phase 2 studies for opioid-induced constipation |
None |
| 2011-08-10 |
Israeli OCS approves $1.7M grant to support PROLOR's hGH-CTP program |
None |
| 2011-08-10 |
Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders |
None |
| 2011-08-10 |
NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers |
5 |
| 2011-08-10 |
Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis |
None |
| 2011-08-10 |
Trastuzumab drug increases risk of heart problems in elderly breast cancer patients |
None |
| 2011-08-10 |
Hydros-TA therapy provides next generation of osteoarthritis relief |
None |
| 2011-08-10 |
Enobia raises US$40M through private placement |
None |
| 2011-08-09 |
Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome |
None |
| 2011-08-09 |
Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study |
None |
| 2011-08-09 |
Lexicon's second quarter revenues decrease 55% to $0.6 million |
None |
| 2011-08-09 |
Genentech, Array BioPharma sign oncology agreement for ChK-1 development program |
None |
| 2011-08-08 |
22nd Century initiates enrollment in Phase II-B clinical trial of X-22 for smoking cessation |
None |
| 2011-08-08 |
Unigene second quarter revenue decreases to $2.5 million |
None |
| 2011-08-08 |
Allergan receives positive opinion from Irish Medicines Board for BOTOX |
None |
| 2011-08-06 |
VIVUS announces additional data from phase 3 QNEXA studies on obesity |
None |
| 2011-08-05 |
Idera second quarter net loss increases to $6.3 million |
None |
| 2011-08-05 |
Alexza resubmits AZ-004 NDA for treatment of agitation in schizophrenia patients |
None |
| 2011-08-05 |
ESC to produce focused update on AF Guidelines following early termination of PALLAS Trial |
None |
| 2011-08-05 |
Takeda, Amylin discontinue pramlintide/metreleptin development program for obesity |
None |
| 2011-08-05 |
YM BioSciences reports preclinical results of CYT387 in multiple myeloma |
None |
| 2011-08-05 |
FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes |
None |
| 2011-08-05 |
Positive results from Antares Pharma VIBEX MTX clinical study on RA |
None |
| 2011-08-05 |
OncoGenex second quarter revenue increases to $1.9 million |
None |
| 2011-08-04 |
Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema |
None |
| 2011-08-04 |
Palatin confirms initiation of AZD2820 Phase 1 trial in obesity |
None |
| 2011-08-04 |
Positive results from hGH-CTP Phase II trial in growth hormone deficient adults |
None |
| 2011-08-04 |
NIH-funded study to assess biomarkers in the blood of TBI patients |
None |
| 2011-08-04 |
Pharming, Santarus reach SPA agreement with FDA for RHUCIN Phase III trial |
None |
| 2011-08-03 |
Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia |
None |
| 2011-08-03 |
Positive results from combination drug trial for late-stage ovarian cancer |
None |
| 2011-08-03 |
Risperidone does not appear to reduce military-related PTSD symptoms |
None |
| 2011-08-03 |
Memantine drug could boost cognitive function in people with Down syndrome |
5 |
| 2011-08-03 |
GSK, NPS enter agreement to evaluate ronacaleret in new indications |
None |
| 2011-08-02 |
ARIAD reports $47.8 million net loss for second quarter 2011 |
None |
| 2011-08-02 |
AstraZeneca recruits patients for KODIAC Phase III trial in opioid-induced constipation |
None |
| 2011-08-02 |
Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma |
4 |
| 2011-08-02 |
Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM |
None |
| 2011-08-02 |
Can-Fite commences CF101 phase 2/3 trial for treatment of Psoriasis |
None |
| 2011-08-01 |
Femta files IND with FDA for FM101 monoclonal antibody against RA |
None |
| 2011-08-01 |
Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer |
None |
| 2011-08-01 |
Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections |
None |
| 2011-08-01 |
Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions |
None |